Max Robotics — Global Service Robot Directory + US Certification

About

Erman Wu is a pioneering researcher at the intersection of urologic oncology, artificial intelligence, and robotic surgery. His work centers on transforming prostate cancer treatment through intelligent, data-driven approaches. Wu’s major contributions include developing the RARPKB, a knowledge-guided decision support platform that personalizes robot-assisted radical prostatectomy, and creating an AI method using MRI-based anatomic parameters to predict postoperative urinary incontinence—a critical quality-of-life outcome. His highly cited 2024 paper, “Intelligent medicine in focus: the 5 stages of evolution in robot-assisted surgery for prostate cancer,” with 21 citations, maps two decades of surgical progress and explores the future roles of brain-computer interfaces, virtual reality, and the metaverse. With additional impactful studies on interpretable deep learning (using Captum) and surgical decision-making, Wu’s work has garnered over 39 citations, establishing him as a leading voice in precision surgical oncology. His research not only advances technical frontiers but also directly addresses patient-centered outcomes, making him a vital figure for students and researchers interested in the future of AI-driven, personalized medicine.